Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India Pharma and Healthcare Fund · Direct ✕Franklin Build India Fund · Direct ✕

Growth of ₹10,000

Basics

Invesco India Pharma and Healthcare FundFranklin Build India Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseInvescoFranklin
NAV₹10.7800₹166.3646
NAV date20 Nov 202620 Nov 2026
History2 months13.9 years
Expense ratio1.9%1.1%
StarsNot rated★★★★★
Growth Score—55.40

Returns

Invesco India Pharma and Healthcare FundFranklin Build India Fund
1 month+19.78%+7.21%
3 months—−0.40%
6 months—−0.22%
YTD—+0.47%
1 year—−1.28%
3 years (CAGR)—+14.52%
5 years (CAGR)—+17.55%
10 years (CAGR)—+17.55%
Since launch+7.58%+19.75%

Risk

Invesco India Pharma and Healthcare FundFranklin Build India Fund
Volatility—17.4%
Downside volatility—11.0%
Sharpe—0.46
Sortino—0.73
Calmar—0.72
Return / risk—0.83
Deepest fall−11.39%−42.80%
Days to recover14283
Below its high+0.00%−4.51%

Against benchmark

Invesco India Pharma and Healthcare FundFranklin Build India Fund
Alpha—+2.59%
Beta—0.98
R²—81.6%
Up capture—108.1%
Down capture—99.1%
Tracking error—7.5%
Information ratio—0.33
Treynor—0.07

Consistency

Invesco India Pharma and Healthcare FundFranklin Build India Fund
Best 1-year—+122.51%
Middle 1-year—+14.38%
Worst 1-year—−38.19%
1-year periods with a loss—17.2%
Middle 3-year—+21.40%
Positive months—55.6%
Best day+3.62%+4.60%
Worst day−2.74%−9.83%
Worst 5% day−1.53%−1.64%
Positive days48.9%55.7%
NAVs a year48247

SIP of ₹10,000 a month

Invesco India Pharma and Healthcare FundFranklin Build India Fund
5-year XIRR—+16.07%
5-year value—₹9,03,858
3-year XIRR—+5.34%
1-year XIRR—+0.64%

Holdings overlap i

Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
  • Invesco India Pharma and Healthcare Fund: no monthly portfolio filing from Invesco is loaded yet, so it is left out here.
  • Franklin Build India Fund: no monthly portfolio filing from Franklin is loaded yet, so it is left out here.

Search Growth